Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMD NASDAQ:ECOR NASDAQ:MHUA NASDAQ:NEPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$1.23-8.2%$1.56$1.10▼$8.44$3.18M1.72179,712 shs164,987 shsECORelectroCore$4.62-5.9%$6.17$4.47▼$19.49$35.04M0.2784,703 shs132,574 shsMHUAMeihua International Medical Technologies$0.42+4.0%$0.42$0.25▼$1.26$13.25M0.78175,517 shs45,246 shsNEPHNephros$3.90+34.9%$3.69$1.36▼$5.00$41.34M1.1132,945 shs150,623 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%+6.03%+0.41%-57.99%-47.53%ECORelectroCore0.00%-31.76%-38.81%-2.74%-23.64%MHUAMeihua International Medical Technologies0.00%+12.71%-13.71%+34.19%-34.18%NEPHNephros0.00%+14.07%+4.00%+105.26%+82.24%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEMDAethlon Medical1.2257 of 5 stars3.02.00.00.00.00.01.3ECORelectroCore2.2742 of 5 stars3.52.00.00.01.32.50.6MHUAMeihua International Medical Technologies0.8033 of 5 stars0.05.00.00.00.01.70.6NEPHNephros2.3613 of 5 stars3.53.00.00.03.40.80.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 2.00Hold$56.004,452.85% UpsideECORelectroCore 3.00Buy$25.50451.95% UpsideMHUAMeihua International Medical Technologies 0.00N/AN/AN/ANEPHNephros 3.00Buy$5.5041.03% UpsideCurrent Analyst Ratings BreakdownLatest MHUA, ECOR, NEPH, and AEMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025NEPHNephrosMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$4.50 ➝ $6.007/7/2025AEMDAethlon MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon Medical$570K5.59N/AN/A$2.55 per share0.48ECORelectroCore$26.46M1.30N/AN/A$0.15 per share30.80MHUAMeihua International Medical Technologies$96.90M0.14$0.45 per share0.92$6.34 per share0.07NEPHNephros$14.16M2.92$0.02 per share194.89$0.81 per share4.81Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$13.39M-$12.64N/AN/AN/AN/A-221.38%-156.83%8/13/2025 (Estimated)ECORelectroCore-$11.89M-$1.62N/AN/AN/A-47.84%-221.93%-69.17%N/AMHUAMeihua International Medical Technologies$10.84MN/A0.00∞N/AN/AN/AN/AN/ANEPHNephros$70K$0.0732.50∞N/A7.95%15.28%11.93%N/ALatest MHUA, ECOR, NEPH, and AEMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q1 2026AEMDAethlon Medical-$0.68N/AN/AN/AN/AN/A8/7/2025Q2 2025NEPHNephros-$0.0250$0.02+$0.0450$0.02$3.60 million$4.40 million8/6/2025Q2 2025ECORelectroCore-$0.32-$0.35-$0.03-$0.44$7.24 million$7.38 million5/15/2025Q1 2025NEPHNephros-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/AECORelectroCoreN/AN/AN/AN/AN/AMHUAMeihua International Medical TechnologiesN/AN/AN/AN/AN/ANEPHNephrosN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A3.133.13ECORelectroCoreN/A1.101.30MHUAMeihua International Medical TechnologiesN/A5.265.21NEPHNephrosN/A5.924.64Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%ECORelectroCore26.74%MHUAMeihua International Medical Technologies1.17%NEPHNephros41.10%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical1.20%ECORelectroCore13.80%MHUAMeihua International Medical Technologies66.56%NEPHNephros6.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical102.59 million2.55 millionNo DataECORelectroCore507.47 million6.44 millionNot OptionableMHUAMeihua International Medical Technologies62031.90 million10.67 millionNot OptionableNEPHNephros3010.60 million9.89 millionNot OptionableMHUA, ECOR, NEPH, and AEMD HeadlinesRecent News About These CompaniesNephros Second Quarter 2025 Earnings: Beats ExpectationsAugust 10 at 6:17 PM | finance.yahoo.comNephros Inc (NEPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Profitability ...August 9 at 4:10 AM | finance.yahoo.com�Nephros Announces Strong Second Quarter Financial ResultsAugust 7 at 4:00 PM | prismmediawire.comPNephros Announces Strong Second Quarter Financial ResultsAugust 7 at 4:00 PM | globenewswire.com�Nephros Schedules Second Quarter 2025 Financial Results Conference CallJuly 31, 2025 | prismmediawire.comPNephros Schedules Second Quarter 2025 Financial Results Conference CallJuly 31, 2025 | globenewswire.comNephros Inc. (NEPH) Stock Price Today - WSJJuly 4, 2025 | wsj.comJune 2025's Promising Penny Stocks With Growth PotentialJune 23, 2025 | finance.yahoo.comNephros, Inc. (NASDAQ:NEPH) Shares Could Be 37% Below Their Intrinsic Value EstimateJune 23, 2025 | uk.finance.yahoo.comNephros to Host Analyst and Investor Virtual EventMay 30, 2025 | finance.yahoo.comNephros First Quarter 2025 Earnings: Beats ExpectationsMay 10, 2025 | finance.yahoo.comNephros’s new microfilter offers enhanced installation flexibility for bacterial retentionApril 30, 2025 | filtsep.comFNephros Schedules First Quarter 2025 Financial Results Conference CallApril 30, 2025 | finance.yahoo.comNephros expands filtration line with new S100 In-Line filterApril 29, 2025 | investing.comNephros Launches New S100 In-Line MicrofilterApril 28, 2025 | finance.yahoo.comNephros Full Year 2024 Earnings: Beats ExpectationsMarch 28, 2025 | finance.yahoo.comEQS-News: Nephros Announces Fourth Quarter and Fiscal Year 2024 Financial ResultsMarch 8, 2025 | markets.businessinsider.comNephros Announces Fourth Quarter and Fiscal Year 2024 Financial ResultsMarch 7, 2025 | theglobeandmail.comNephros Amends CFO Employment Terms for Strategic GrowthMarch 4, 2025 | tipranks.comNephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2024 Financial ResultsFebruary 26, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesPalantir Gets Price Hike From Wedbush Amid High ValuationBy Chris Markoch | July 15, 2025View Palantir Gets Price Hike From Wedbush Amid High ValuationBig 3 Telecom Wars: 2 Solid Showings, 1 Huge Winner in Q2By Leo Miller | July 29, 2025View Big 3 Telecom Wars: 2 Solid Showings, 1 Huge Winner in Q2Microsoft Blasts Past Earnings—What’s Next for MSFT?By Chris Markoch | July 31, 2025View Microsoft Blasts Past Earnings—What’s Next for MSFT?Onsemi’s August Pullback Is a Signal to Buy for Tech InvestorsBy Thomas Hughes | August 4, 2025View Onsemi’s August Pullback Is a Signal to Buy for Tech InvestorsFull Steam Ahead: The Bullish Case for Carnival StockBy Jeffrey Neal Johnson | July 18, 2025View Full Steam Ahead: The Bullish Case for Carnival StockMHUA, ECOR, NEPH, and AEMD Company DescriptionsAethlon Medical NASDAQ:AEMD$1.23 -0.11 (-8.21%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.28 +0.05 (+4.07%) As of 08/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.electroCore NASDAQ:ECOR$4.62 -0.29 (-5.91%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$4.61 -0.01 (-0.32%) As of 08/8/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Meihua International Medical Technologies NASDAQ:MHUA$0.42 +0.02 (+4.00%) Closing price 08/8/2025 03:57 PM EasternExtended Trading$0.42 +0.00 (+0.24%) As of 08/8/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.Nephros NASDAQ:NEPH$3.90 +1.01 (+34.95%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$3.80 -0.10 (-2.56%) As of 08/8/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
